Clinical, biochemical and metabolic parameters predictors of vascular complications in type 2 diabetics

Authors

  • Ariel Sarduy Rodríguez Facultad de Ciencias Médicas de Bayamo. Bayamo.
  • Eduardo Valdés Ramos Centro de Atención y Educación al Diabético. Bayamo
  • Elio Cruz Manzano Facultad de Ciencias Médicas de Bayamo. Bayamo
  • María Rosario Milanés Ojea Facultad de Ciencias Médicas de Bayamo. Bayamo
  • Gonzalo Rafael Mompié Gómez Facultad de Ciencias Médicas de Bayamo. Bayamo

Keywords:

Type 2 diabetes mellitus, Diabetes complications, Risk factors.

Abstract

Introduction: Diabetes Mellitus is one of the main syndromic entities in normal clinical practice, with an increase in prevalence, which is worrying, because of the disease itself and the chronic vascular complications that occur in these patients.
Objective: to identify the clinical, biochemical and metabolic parameters that predict vascular complications in people with type 2 diabetes mellitus.

Method: an analytical study of cases and controls was conducted with patients admitted to the Bayamo Diabetic Care Center (CAD), Granma, from 2010 to 2017, 81 with some vascular complication and 162 without any.

Results: in the univariate analysis it was observed that the time of evolution of the disease was the only risk factor for the development of a vascular complication. By associating this variable with other hypothetically influential factors, it was found that factors such as age as a risk factor according to sex, smoking, alcoholism, poor metabolic control and the presence of metabolic syndrome, impaired fasting blood glucose, hypertriglyceridemia, hypercholesterolemia, general, abdominal obesity and uncontrolled hypertension appear as statistically significant risk factors. The variables that showed an independent relationship with the risk of developing a vascular complication were the time of evolution of the disease and the presence of metabolic syndrome.

Conclusions: the time of evolution of diabetes and metabolic syndrome are independently associated with the appearance of vascular complications in people with type 2 diabetes mellitus.

Downloads

Download data is not yet available.

References

1. Font Difour MV, del Valle García N, Sánchez Bonne AH, Gallego Galano J, Lashey Olivares ML. Caracterización de pacientes diabéticos de tipo II con complicaciones vasculares y riesgo de ateroesclerosis. MEDISAN 2014; 18(12): 1664-1670.

2. Valdés Ramos E, Camps Arjona MC, de Jesús Escalona F. Frecuencia y factores asociados al tratamiento con insulina en diabéticos tipo 2 de la provincia Granma. Rev Cubana Med 2014; 53(2): 116-126.

3. Kassa Birarra M, Asmelashe Gelayee D. Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study. BMC Cardiovasc Disord 2018; 18: 149.

4. Fekadu Wolde H, Atsedeweyen A, Jember A, Awoke T, Mequanent M, Tesfahun Tsegaye A, Alemu S. Predictors of vascular complications among type 2 diabetes mellitus patients at University of Gondar Referral Hospital: a retrospective follow-up study. BMC Endocr Disord [Internet]. 2018 [citado 21/1/2018]; 18(52). Disponible en: https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-018-0280-0

5. Toth P, Simko RJ, Rao Palli S, Koselleck D, Quimbo RA, Cziraky MJ. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 2012; 11: 109.

6. Agudelo M, Dávila CA. Burden of mortality due to diabetes mellitus in Latin America 2000-2011: the case of Argentina, Chile, Colombia, and Mexico. Gac Sanit 2015; 29(3): 172-77.

7. International Diabetes Federation. The IDF Diabetes Atlas. 8va Ed. [Internet]. Brussels: International Diabetes Federation; 2017 [citado 21/1/2018]. Disponible en: https://www.idf.org/component/attachments/attachments.html?id=1407&task=download

8. MINSAP. Anuario Estadístico de Salud, 2017. [Internet]. La Habana: MINSAP; 2018. [citado 1/1/2018]. Disponible en: http://files.sld.cu/dne/files/2018/04/Anuario-Electronico-Espa%C3%B1ol-2017-ed-2018.pdf

9. Tracey Marsha L, McHugh Sheena M, Fitzgerald Anthony P, Buckley Claire M, Canavan Ronan J, Kearney Patricia M. Risk Factors for Macro- and Microvascular Complications among Older Adults with Diagnosed Type 2 Diabetes: Findings from The Irish Longitudinal Study on Ageing. J Diabet Res [Internet]. 2016 [citado 21/1/2018]; 2016. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884580/

10. Céspedes Miranda EM, Riverón Forment G, Alonso Rodríguez C, Cabrera Pérez-Sanz E. Control glucémico y daño oxidativo a biomoléculas en diabéticos tipo 2. Rev Cubana Endocrinol 2014; 25(2): 46-56.

11. American Diabetes Association. Standards of Medical Care in Diabetes-2013. Classification and diagnosis. Diabetes Care 2013; 36(suppl 1): S11-S66.

12. Expert Panel, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP), Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Treatment Panel III). JAMA 2001; 285(19): 2486-97.

13. Chawla A, Chawla R, Jaggi S. Microvascular and macrovascular complications in diabetes mellitus: ¿Distinct or continuum? Indian J Endocrinol Metab 2016; 20(4): 546–551.

14. American Diabetes Association. Standards of medical care in diabetes-2016: Summary of revisions. Diabetes Care 2016; 39(Suppl 1): S4-S5.

15. Alaboud AF, Tourkmani AM, Pharm D, Alharbi TJ, Alobikan AH, Abdelhay O, et al. Microvascular and macrovascular complications of type 2 diabetic mellitus in Central, Kingdom of Saudi Arabia. Saudi Med J 2016; 37(12): 1408–1411.

16. Potier L, Chequer R, Roussel R, Mohammedi K, Sismail S, Hartemann A, et al. Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus. Cardiovasc Diabetol. [Internet]. 2018 [citado 10/3/2018]; 17(11). Disponible en: https://cardiab.biomedcentral.com/articles/10.1186/s12933-017-0652-1

17. Pompa Carrazana SG, Álvarez Aliaga A, Duany Almira LF. Factores de riesgo para el desarrollo de complicaciones crónicas en pacientes diabéticos tipo 2. Convención Internacional de Salud, Cuba Salud 2018. [Internet]. 2018 [citado 10/3/2018]. Disponible en: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&ved=2ahUKEwj88cjsi4boAhVBh-AKHTa8AEUQFjABegQICxAE&url=http%3A%2F%2Fwww.convencionsalud2018.sld.cu%2Findex.php%2Fconnvencionsalud%2F2018%2Fpaper%2Fdownload%2F797%2F300&usg=AOvVaw3z3LsfQdAw7B-Pu2zz5kZ8

18. Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ. Rates of Complications and Mortality in Older Diabetes Patients: The Diabetes and Aging Study. JAMA Intern Med 2014; 174(2): 251–258.

19. Fekadu H, Atsedeweyen A, Jember A, Awoke T, Mequanent M, Tesfahun A, et al. Predictors of vascular complications among type 2 diabetes mellitus patients at University of Gondar Referral Hospital: a retrospective follow-up study. BMC Endocr Disord [Internet]. 2018 [citado 10/3/2018]; 18(52). Disponible en: https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-018-0280-0

20. Hua Yang, Doris Young, Jian Gao, Yuanzhi Yuan, Minqian Shen, Yuan Zhang, et al. Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China. Lipids Health Dis [Internet]. 2019 [citado 11/8/2018]; 18. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339385/

21. Wang YL, Koh WP, Talaei M, Yuan JM, Pan A. The association between the ratio of triglyceride to high-density lipoprotein cholesterol and incident type 2 diabetes in Singapore Chinese men and women. J Diabetes 2017; 9(7): 689–698.

22. Jinbo Hu, Shumin Yang, Aipin Zhang, Ping Yang, Xueting Cao, Xiyue Li, Richa Goswami, Yue Wang, Ting Luo, Kun Liao, Qingfeng Cheng, Xiaoqiu Xiao, and Qifu Li. Abdominal Obesity Is More Closely Associated With Diabetic Kidney Disease Than General Obesity. Diabetes Care 2016; 39: 179-180.

23. Valdés Ramos ER, Espinosa Benítez Y. Factores de riesgo asociado con la aparición de enfermedad arterial periférica en personas con diabetes mellitus tipo 2. Rev Cubana Med 2013; 52(1): 4-13.

24. Kim TK, Won JY, Shin JA, Park YM, Yim HW, Park YH. The Association of Metabolic Syndrome with Diabetic Retinopathy: The Korean National Health and Nutrition Examination Survey 2008–2012. PLoS ONE 2016; 11(6): e0157006.

25. Śliwińska-Mossoń M, Milnerowicz H. The impact of smoking on the development of diabetes and its complications. Diab Vas Dis Res 2017; 14(4): 265–276.

Downloads

Published

2020-02-17

How to Cite

1.
Sarduy Rodríguez A, Valdés Ramos E, Cruz Manzano E, Milanés Ojea MR, Mompié Gómez GR. Clinical, biochemical and metabolic parameters predictors of vascular complications in type 2 diabetics. RM [Internet]. 2020 Feb. 17 [cited 2025 Jun. 4];24. Available from: https://revmultimed.sld.cu/index.php/mtm/article/view/1854

Issue

VOL.24 (2020): Suplemento 1

Section

ARTÍCULOS ORIGINALES

License

Avisos de derechos de autor propuestos por Creative Commons

1. Política propuesta para revistas que ofrecen acceso abierto

Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
  1. Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
  2. Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
  3. Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).